CPBTD
BBIO icon

Central Pacific Bank - Trust Division’s BridgeBio Pharma BBIO Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$479K Sell
7,274
-493
-6% -$38.4K 0.05% 306
2026
Q2 		$578K Hold
7,767
– – 0.06% 297
2026
Q1 		$577K Sell
7,767
-2,549
-25% -$185K 0.07% 259
2025
Q4 		$789K Buy
+10,316
New +$677K 0.1% 222

Other funds holding BBIO

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
RWS
Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

Central Pacific Bank - Trust Division's BBIO Position: Q3 2026 in Review

Central Pacific Bank - Trust Division reduced its BridgeBio Pharma (BBIO) stake by 6.3% in Q3 2026, selling an estimated $38.4K and leaving 7,274 shares worth $479K. The position accounts for 0.05% of the portfolio, ranked #306.

Central Pacific Bank - Trust Division first reported a position in BBIO in Q4 2025 and has held it in 4 quarters since. The position peaked at $789K in Q4 2025. 12 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • Central Pacific Bank - Trust Division held 7,274 shares of BridgeBio Pharma worth $479K as of Q3 2026.
  • Central Pacific Bank - Trust Division sold 493 BridgeBio Pharma shares in Q3 2026, an estimated $38.4K.
  • BridgeBio Pharma made up 0.05% of Central Pacific Bank - Trust Division's portfolio in Q3 2026, its #306 holding.
  • Central Pacific Bank - Trust Division first reported a position in BridgeBio Pharma in Q4 2025 and has held it in 4 quarters since.
  • Central Pacific Bank - Trust Division's BridgeBio Pharma position peaked at $789K in Q4 2025.
  • 12 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.